Jeff Brock, PharmD, MBA, BCIDP

I routinely see prescribers avoid prescribing cephalosporin antibiotics for patients with a penicillin allergy.

It is estimated that approximately one-quarter of the world’s population has latent tuberculosis infection (LTBI). Although effective therapies are available, these agents can have significant adverse effects that can complicate treatment.

As health care workers, we have daily encounters with sick patients who could potentially have a contagious illness. Measles is a particular challenge in the health care setting.

Zika virus is an important mosquito-borne pathogen with significant public health concerns. Zika vaccine development is an ongoing area of research with several candidates in the pipeline.

Antibiotic use in asymptomatic bacteriuria (ASB) is a commonly encountered issue for a stewardship pharmacist and one of the most frustrating.

There has been an alarming increase in extensively drug-resistant Shigella infections reported through national surveillance systems.

Over the past several years, adult pneumococcal vaccine recommendations have evolved based on the development of new vaccines.

Herpes simplex encephalitis (HSE) is likely the most serious herpes infection patients can face. Treatment options for HSE are very limited, with IV acyclovir the only approved antiviral for this devastating infection.

Azole-resistant Aspergillus fumigatus has become an increasing problem worldwide over the last decade.

The proportion of people living with HIV (PLWH) who are older than age 50 years is increasing, such that in 2018, approximately 50% of PLWH fell into this category.